At the IASLC 2024 World Conference on Lung Cancer in San Diego, a new study has demonstrated that AI-powered chest X-ray ...

Alchemab Therapeutics has appointed Jane Osbourn, the company’s Co-Founder and Chief Scientific Officer, as Chief Executive ...

There is currently no national screening programme for the disease in the UK Oncologica has developed a urine-based screening test for prostate cancer and has launched a funding drive to support its ...

Leeds Teaching Hospitals NHS Trust (LTHT) has announced that it is piloting a new artificial intelligence (AI) and machine learning software system for prostate cancer diagnosis. Working in ...

Promising results for novel orexin agonist in sleep-deprived volunteers Nxera Pharma, formerly known as Sosei Group, has announced that its partner, Centessa Pharmaceuticals, has reported encouraging ...

The conference will return to Vienna AirportCity on 23 to 24 October 2024 Samedan has announced that on 23 to 24 October 2024, its FlyPharma Conference will make a welcome return to Office Park 4, ...

A recent study published in the American Journal of Psychiatry suggests that menopausal hormone therapy (HRT) may reduce the risk of psychosis relapse in menopausal women. The research, led by Bodyl ...

APL, one of Sweden’s largest manufacturers of extemporaneous medicines and a leading contract development and manufacturing organization (CDMO), has announced a partnership with CurifyLabs, a Finnish ...

World Sepsis Day, observed annually on 13 September, aims to raise awareness about sepsis, a life-threatening condition that claims millions of lives each year. Sepsis results from a dysregulated ...

Patients with relapsed multiple myeloma gain access to life-extending therapy The Scottish Medicines Consortium (SMC) has approved Tecvayli – also known as teclistamab – for patients with relapsed and ...